- Home
- ES vs BNTX Comparison
ES vs BNTX Comparison
Compare ES & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ES
- BNTX
- Stock Information
- Founded
- ES 1927
- BNTX 2008
- Country
- ES United States
- BNTX Germany
- Employees
- ES N/A
- BNTX N/A
- Industry
- ES Electric Utilities: Central
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ES Utilities
- BNTX Health Care
- Exchange
- ES Nasdaq
- BNTX Nasdaq
- Market Cap
- ES 22.7B
- BNTX 23.9B
- IPO Year
- ES N/A
- BNTX 2019
- Fundamental
- Price
- ES $59.76
- BNTX $121.72
- Analyst Decision
- ES Buy
- BNTX Strong Buy
- Analyst Count
- ES 14
- BNTX 14
- Target Price
- ES $68.86
- BNTX $141.60
- AVG Volume (30 Days)
- ES 2.0M
- BNTX 1.1M
- Earning Date
- ES 11-04-2024
- BNTX 11-04-2024
- Dividend Yield
- ES 4.78%
- BNTX N/A
- EPS Growth
- ES N/A
- BNTX N/A
- EPS
- ES N/A
- BNTX N/A
- Revenue
- ES $11,623,559,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- ES $7.50
- BNTX N/A
- Revenue Next Year
- ES $4.22
- BNTX N/A
- P/E Ratio
- ES N/A
- BNTX N/A
- Revenue Growth
- ES N/A
- BNTX N/A
- 52 Week Low
- ES $52.09
- BNTX $76.53
- 52 Week High
- ES $69.01
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- ES 34.57
- BNTX 60.69
- Support Level
- ES $61.07
- BNTX $112.96
- Resistance Level
- ES $65.21
- BNTX $121.80
- Average True Range (ATR)
- ES 1.19
- BNTX 5.01
- MACD
- ES -0.14
- BNTX 1.07
- Stochastic Oscillator
- ES 1.62
- BNTX 86.57
About ES Eversource Energy (D/B/A)
Eversource Energy is a diversified holding company with subsidiaries that provide rate-regulated electric, gas, and water distribution service to more than 4 million customers in the Northeast U.S. The company expanded its service territories with acquisitions of NStar (2012), Aquarion (2017), and Columbia Gas (2020). In 2024 Eversource exited its 50% partnership with European utility Orsted to develop 2 gigawatts of offshore wind projects in the Northeast U.S. The company exited most of its unregulated businesses in 2006.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.